Franz Koenig
Medizinische Universität Wien
H-index: 47
Europe-Austria
Top articles of Franz Koenig
Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARL
2024/1/1
Franz Koenig
H-Index: 29
Martin Posch
H-Index: 31
Guillermo Fernández
H-Index: 11
Lucinda Cash-Gibson
H-Index: 5
Marta Bofill Roig
H-Index: 2
Martin Brunner
H-Index: 36
Melisa Kose
H-Index: 2
Francesco Benedetti
H-Index: 7
Christian Otte
H-Index: 37
Eugenia Kulakova
H-Index: 8
Frank Tacke
H-Index: 77
Stefan Gold
H-Index: 25
Peter Jacko
H-Index: 13
Scott Berry
H-Index: 15
Sergio Contrino
H-Index: 11
Hannes Jarke
H-Index: 4
Katharina Hees
H-Index: 8
Quynh Nguyen
H-Index: 18
Mario Raviglione
H-Index: 65
Simone Villa
H-Index: 7
Gareth Evans
H-Index: 3
Adaptive clinical trial designs with blinded selection of binary composite endpoints and sample size reassessment
Biostatistics
2024/1/1
Marta Bofill Roig
H-Index: 2
Guadalupe Gómez Melis
H-Index: 16
Martin Posch
H-Index: 31
Franz Koenig
H-Index: 29
Simultaneous inference procedures for the comparison of multiple characteristics of two survival functions
arXiv preprint arXiv:2310.01990
2023/10/3
Regulatory Issues of Platform Trials: Learnings from EU‐PEARL
2024/3/26
Developing generic templates to shape the future for conducting integrated research platform trials
2023/10/17
Franz Koenig
H-Index: 29
A two-step approach for analyzing time to event data under non-proportional hazards
arXiv preprint arXiv:2402.08336
2024/2/13
Clopidogrel for Proteinuria Reduction in Focal Segmental Glomerulosclerosis: Phase 2 Trial Design
Kidney International Reports
2024/2/1
Franz Koenig
H-Index: 29
Designing an exploratory phase 2b platform trial in NASH with correlated, co-primary binary endpoints
Plos one
2023/3/9
The von Willebrand factor–binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A
Blood
2023/3/9
Platform trials to overcome major shortcomings of traditional clinical trials in non-alcoholic steatohepatitis? Pros and Cons
2023/2/1
Frank Tacke
H-Index: 77
Franz Koenig
H-Index: 29
patient-oriented drug development pathways in NASH—setting the scene for platform trials
2023
Franz Koenig
H-Index: 29
Pilot Pharmacokinetic Study in Healthy Adults Using Intravascular Microdialysis Catheters Modified for Use in Paediatric Patients to Assess Vancomycin Blood Levels
Clinical Pharmacokinetics
2023/1
Efficiency of Multivariate Tests in Trials in Progressive Supranuclear Palsy
arXiv preprint arXiv:2312.08169
2023/12/13
2383. Immunogenicity and reactogenicity of a first booster with BNT162b2 or full-dose mRNA-1273: a randomised trial in adults≥ 75 years (EU-COVAT-1) from the VACCELERATE …
Open Forum Infectious Diseases
2023/12
Immunogenicity and reactogenicity of a first booster with BNT162b2 or full-dose mRNA-1273: A randomised VACCELERATE trial in adults≥ 75 years (EU-COVAT-1)
2023/6/2
A neutral comparison of statistical methods for time-to-event analyses under non-proportional hazards
arXiv preprint arXiv:2310.05622
2023/10/9
Design Considerations for a Phase II platform trial in Major Depressive Disorder
arXiv preprint arXiv:2310.02080
2023/10/3
IMUNOGENICIDADE DE UM PRIMEIRO REFORÇO COM BNT162B2 OU MRNA-1273 DE DOSE COMPLETA: UM ESTUDO RANDOMIZADO EM ADULTOS≥ 75 ANOS (EU-COVAT-1) DO CONSÓRCIO VACCELERATE
The Brazilian Journal of Infectious Diseases
2023/10/1
SIMPLE—A modular tool for simulating complex platform trials
SoftwareX
2023/7
Peter Jacko
H-Index: 13
Franz Koenig
H-Index: 29
Co-Authors
